UNIVERSITE DE ROUEN NORMANDIE

Their core work

Université de Rouen Normandie is a French public university with strong research capabilities in nuclear materials science, advanced analytical chemistry, and applied biosciences. Their nuclear expertise focuses on understanding radiation damage, material ageing in reactors, and tritium behavior — contributing specialist knowledge to major European nuclear safety programs. They also bring expertise in high-resolution mass spectrometry (FT-ICR), plant-based pharmaceutical production, and combustion science for cleaner transport. Their work bridges fundamental materials research with applied safety and environmental challenges.

What they specialise in

How they've shifted over time

In the early H2020 period (2014–2017), Rouen's participation was broad and exploratory — spanning solar cell materials (Sharc25), social sciences (CHIBOW), and initial nuclear safety work (EUROfusion, SOTERIA). From 2018 onward, their profile sharpened significantly around two poles: nuclear materials safety (ENTENTE, STRUMAT-LTO adding to existing fusion work) and applied biosciences (Pharma-Factory, FT-ICR mass spectrometry). The recent keyword concentration on safety, irradiation ageing, and molecular farming signals a university consolidating around its distinctive strengths rather than spreading thin.

Rouen is deepening its nuclear materials safety expertise while building a parallel biosciences capability — expect continued growth in both reactor lifetime assessment and plant-based pharmaceutical research.

How they like to work

Rouen never coordinates H2020 projects — they contribute specialist expertise as either a participant (7 projects) or third party (7 projects), typically embedded in large European consortia. With 323 unique partners across 37 countries, they are well-connected but clearly positioned as a knowledge contributor rather than a project driver. The high proportion of third-party roles (50%) suggests they are often brought in for specific technical capabilities — particularly in nuclear materials characterization — rather than shaping project direction.

Extensive European network spanning 323 unique partners across 37 countries, built primarily through large nuclear research consortia (EUROfusion alone connects dozens of institutions). Their reach is broad but the relationships are consortium-mediated rather than bilateral.

What sets them apart

Rouen combines deep nuclear materials expertise — especially in irradiation ageing and post-irradiation examination — with strong analytical chemistry capabilities (FT-ICR mass spectrometry) that few universities can match. This combination makes them valuable for projects needing both materials characterization and advanced analytical methods. For consortium builders in nuclear safety or decommissioning, they offer reliable third-party expertise without the overhead of coordinating with a large research center.

Highlights from their portfolio

• CORE
  Largest single grant (EUR 789K) in a focused chemistry project on chiral compound crystallization — shows strong independent research capacity beyond their nuclear work.
• Pharma-Factory
  EUR 532K for plant-based pharmaceutical production including HIV and rheumatoid arthritis treatments — demonstrates applied bioscience capability with direct commercial relevance.
• STRUMAT-LTO
  Most recent nuclear safety project (2020–2024) on structural materials for long-term reactor operation — represents the current frontier of their core expertise.